Nyxol

phentolamine ophthalmic solution 0.75% · Ocuphire Pharma, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Nyxol, covering 2023-08-01 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis [Phase 3]

See pricing